Advanced or metastatic solid tumors Clinical Trials EU — 16 Studies

Filter these 16 trials by phase, country, sponsor and more.

Open in Search →

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting

2025-523686-15-00 1 2026-04-08
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors Recruiting

2025-524334-26-01 1 2026-03-26
A Study to test ALE.P03 in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors Recruiting

2025-521441-24-00 7 2026-01-19
A Study of Orally Administered MOMA-313 in Participants with Advanced or Metastatic Solid Tumours Recruiting

2024-513502-62-00 1 2025-03-07
A Phase I/II Study of AZD5863 in Adult Participants with Advanced or Metastatic Solid Tumors Recruiting

2023-504139-42-00 7 2024-09-06
Study of INBRX-109 in Patients with Advanced Solid Tumors, Including Sarcomas. Recruiting

2023-508139-29-00 7 2024-06-26
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors Recruiting

2022-502456-31-00 1 2023-11-30
FIPO23 Phase I/II, multi center, Open Label, First-in-human, Dose Escalation and Expansion study to investigate the Safety, Pharmacokinetics … Recruiting

2023-505266-29-00 7 2023-11-14
A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Sele … Recruiting

2024-512822-28-00 1 2022-08-08
Clinical trial of MK-1484 given alone and with pembrolizumab in adults with solid tumors Recruitment ended

2023-505067-36-00 1 2022-06-22
A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors with KRAS G12D Mutation Halted

2023-507091-47-00 1 2025-02-10
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the DG … Ended

2023-503996-38-00 1 2025-05-21
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3 … Ended

2023-505322-34-00 1 2024-01-08
Study of ART0380 in Advanced/Metastatic Solid Tumors Patients (ARTIST) Ended

2023-504153-12-00 4 2023-12-07
A Drug Absorption Study of MK-3475A in Participants with Solid Tumors Ended

2023-505340-19-00 3 2021-09-20
This study aims to find the best dose of BI 907828 (brigimadlin) in patients with different types of advanced cancer (solid tumors) Ended

2024-511503-41-00 3 2021-08-13

Showing 1–16 of 16 trials